BioSpace News Archive

Knowles Precision Devices, a division of Knowles Corporation, recently introduced the MD Series, a range of medical-grade capacitors for implantable designs.

Apnimed, Inc. announced the company will be participating in several investor conferences in September 2023.

Pliant Therapeutics, Inc. announced participation in the following September investor conferences.

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) today announced that the Company will virtually present at the H.C. Wainwright 25th Annual Global Investment Conference, being held September 11-13, 2023.

Cabaletta Bio, Inc. announced that the Company will participate in four upcoming investor conferences in September:

CRISPR Therapeutics announced that members of its senior management team are scheduled to participate in a fireside chat at Citi’s 18th Annual Biopharma Conference being held from September 6-7, 2023.

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company’s interim report for the period January-June 2023, has been published.

Asieris Pharmaceuticals announced that the National Medical Products Administration has approved the Investigational Drug application for its oral drug APL-1401 for the treatment of moderately-to-severely active ulcerative colitis.The IND application had previously been approved by the U.S. Food and Drug Administration.

SOPHiA GENETICS announced that CHU Bordeaux, a full-service hospital servicing the population of Bordeaux and the surrounding area, has completed implementation of the SOPHiA DDM™ Platform into its organization.

Karuna Therapeutics, Inc. announced that management will present at the following upcoming investor conferences.